The Effect of Myo-inositol Pretreatment on ICSI/IVF Outcome for Infertile Patients with Polycystic Ovary Syndrome

Successful pregnancy and childbirth are among the most critical periods of life for women, and any factor affecting their fertility can have mental and social challenges for their life. Thus, examining the diseases that affect the physical and mental characteristics of women as sensitive and vulnerable members of society is very important. Polycystic Ovary Syndrome (PCOS) is one of these diseases .The current study examines myo-inositol pretreatment's effect on ICSI/IVF outcomes for infertile patients with polycystic ovary syndrome. Fifty-four patients with IVF with polycystic ovary diagnostic criteria were included in the study. They were divided into control and intervention groups based on basic experiments with block randomization methods. Data was analyzed by using descriptive and analytic statistics in Strata software. The significance level was designed at 0.05. The mean ovule at metaphase II, inoculation, number of zygote 2PN, freezing period, and infertility in the intervention group were significantly higher than in the control group. A significant decrease in side effects of Myo-inositol has made it desirable for patients with polycystic ovary syndrome.